EP1832285A1 — Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
Assigned to Abbott GmbH and Co KG · Expires 2007-09-12 · 19y expired
What this patent protects
A formulation comprising i) fenofibric acid or a physiologically acceptable salt of fenofibric acid, and optionally other active substances, ii) a binder component comprising at least one non-enteric binder and at least one enteric binder, and optionally iii) other physiologicall…
USPTO Abstract
A formulation comprising i) fenofibric acid or a physiologically acceptable salt of fenofibric acid, and optionally other active substances, ii) a binder component comprising at least one non-enteric binder and at least one enteric binder, and optionally iii) other physiologically acceptable excipients is described.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.